ALDH2 and Alzheimer disease: Therefore, activating ALDH2∗2 and increasing ALDH2-related compounds, such as Alda-1 (an activator of ALDH2 and ALDH2∗2), could be a potential therapeutic approach to slow down AD pathogenesis.